KYMR

Kymera Therapeutics Inc (KYMR)

US
$ 44.360.29%

Price Chart

Key Statistics

Market Cap
$ 3.12B
P/E Ratio
0.00
Revenue (TTM)
$ 58.89M
Volume
907.31K
52W High
$ 53.27
52W Low
$ 19.45
Dividend Yield
0.00%
Beta
2.07

Technicals

50-Day MA
39.1436
200-Day MA
39.3413
52 Week High
53.27
52 Week Low
19.445

About KYMR

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing.

Employees
208
Headquarters
Watertown, MA
CEO
Dr. Bruce L. Booth DPHIL, Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96